Bodal Chemicals Limited — Important, 14-11-2024: Financial Result Updates

Bodal Chemicals has announced a board meeting to present the consolidated financial results for the quarter and half-year ended September 30, 2024.

Total revenue reached ₹4,337.06 crore, reflecting a 28.9% increase compared to ₹3,359.29 crore in the corresponding period last year. This growth can be attributed to higher demand, market expansion initiatives, and strategic operational efficiencies.

Net profit for the period stood at ₹12.42 crore, compared to a loss of ₹11.75 crore in the previous year, showcasing a significant turnaround. Earnings per Share (EPS) for this quarter improved to ₹0.05, contrasting sharply with a loss per share of ₹0.09 in the previous period. This upturn suggests enhanced operational performance despite challenges posed by rising costs.

Operating expenses totaled ₹4,327.21 crore, up 1.6% year-on-year, with notable increases in raw material costs and employee benefits, reflecting ongoing inflationary pressures. The company’s focus on cost management in other areas, including finance costs, helped cushion the impact.

The balance sheet remains robust, with total assets at ₹22,287.11 crore, slightly down from ₹22,878.80 crore. Liquidity indicators appear stable, with sufficient cash flows to support operations and growth initiatives.

Strategically, the outlook appears positive, promoting a focus on innovation and cost efficiency amid a recovering economic landscape. Given these financials, investors may consider a buy position, recognizing the potential for continued recovery and growth opportunities in the chemical sector.